Clinical Trial Update: Use of Rosiglitazone in the Treatment of Endometriosis [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating rosiglitazone for endometriosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Endometriosis | Phase 2 | Status: TERMINATED